Neodolor (Cyclamen Purpurascens Trit. D 3, Cimicifuga Racemosa Trit D2, Gelsemium Sempervirens Trit. D2, Iris)

Cyclamen Purpurascens, along with the other botanical ingredients, undergoes serial dilution and succussion. In homeopathic theory, this process transfers the informational imprint of the source material to the diluent, which is then believed to stimulate the body's self‑regulatory mechanisms and modulate pathways related to pain and stress.

The appropriate dose of Neodolor is determined by the prescribing healthcare professional based on individual patient needs, the specific indication, and the potency of the preparation. Patients should follow the prescriber's instructions and not alter the dosage without medical advice.

Pregnant or breastfeeding individuals should discuss the use of Neodolor with a qualified healthcare provider. While homeopathic products are generally considered low risk, professional guidance is essential to evaluate any potential concerns specific to the patient’s condition.

To place an order, submit an enquiry on the Neodolor product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Neodolor differs from conventional analgesics in that it is a homeopathic preparation that contains highly diluted botanical extracts rather than pharmacologically active compounds. While conventional analgesics provide direct chemical pain relief, Neodolor aims to support the body's innate healing response. Clinical outcomes may vary, and patients should consult their clinician to determine the most appropriate therapy.

Neodolor should be stored at ambient temperature, preferably below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain its stability and potency.

Neodolor is administered orally, typically as a tablet, lozenge, or liquid dropper, depending on the specific product format supplied. The prescriber will provide detailed instructions on the route of administration, frequency, and duration of therapy.

Serious but rare risks include anaphylactic reactions, severe dermatitis, and respiratory distress. Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, widespread rash, or swelling after taking the product.

Neodolor should be avoided by individuals with known hypersensitivity to any of its listed ingredients, children under 12 years of age without medical supervision, and patients who are currently on immunosuppressive therapy or anticoagulants unless a healthcare professional determines it is safe.